Role of cell division cycle associated 2 in ovarian cancer: Effects on tumor progression and cisplatin resistance
CDCA2 knockdown inhibited the development of ovarian cancer through the AKT/mTOR pathway and enhanced cisplatin sensitivity. CDCA2 is a potential target to reverse cisplatin resistance in ovarian cancer. It can also be used as a new research direction for the development of ovarian cancer therapy.
Authors
- Xueyun Xu
- Wei Li (ORCID: https://orcid.org/0000-0001-6728-1300)
- Yanyan Jin (ORCID: https://orcid.org/0000-0001-9974-1287)
Institutions
- Affiliated Hospital of Jining Medical University (CN)
Publication Details
- Journal
- CytoJournal
- Published
- 2025-09-10
- DOI
- https://doi.org/10.25259/cytojournal_59_2025
- Citations
- 1
- Primary Topic
- Cancer Mechanisms and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 1.47